|
Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer
Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information
Basic Trial Information
| Phase | Type | Status | Age | Protocol IDs |
|---|
| Phase III | Supportive care, Treatment | Active | 18 and over | VRAM M-20070240
NCT00647569 |
Trial Description
Summary The aim of the present project is to investigate whether use of biological mesh at the donor site of the rotation flap in closure of the abdominal wall reduce the frequency of incisional hernia formation compared to the usual abdominal wall closure after abdominal rotation flap operation in surgery for advanced pelvic cancer. Eligibility Criteria Inclusion Criteria: - Patients operated with a vertical rectus abdominis musculocutaneus flap after abdominoperineal resection for advanced pelvic cancer.
Exclusion Criteria: - Pre or perioperative knowledge of disseminated malignancy
- Unable to follow the control program
- Compromised immune defense
- Artificial heart valve or recent (< 3 months) implanted foreign body
Trial Contact Information
Trial Lead Organizations/Sponsors Aarhus Universitetshospital - Aarhus Sygehus Cook Biotech Incorporated
| Peter Christensen, M.D., Ph.d |  | Principal Investigator |
Trial Sites
|
|
|
|
| Denmark |
|
| |
Aarhus |
|
| | | | | | | | Aarhus Universitetshospital - Aarhus Sygehus |
| | | Peter Christensen |
Ph: +45 8949 7527 |
| |
Email:
piz@webspeed.dk |
| | | Peter Christensen | Principal Investigator |
|
Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00647569
Information obtained from ClinicalTrials.gov on March 18, 2009 Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain
the same text. Minor
changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and
contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should
be directed to ClinicalTrials.gov.
Back to Top |
